Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia [Phase 3]
Phase 3 clinical trial evaluating oral minoxidil 1 mg for female androgenetic alopecia is currently not recruiting.
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia [NA]
A clinical trial assessing stromal vascular fraction versus platelet-rich plasma for androgenetic alopecia; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III). [NA]
This clinical study aims to evaluate safety, efficacy, and in-use tolerability of different dosages of hair growth products in patients with…
-
FDA approval · 2024-08-09FDA Approved: MINOXIDIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for MINOXIDIL from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia [Phase 1]
Phase 1 clinical trial to evaluate efficacy and safety of AGE ZERO EXOSOMES for treating androgenetic alopecia in men and women; the study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia [Phase 2]
A Phase 2 trial of CKD-498 in female patients with androgenetic alopecia has completed, assessing safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the safety and efficacy of KX-826 in Chinese female subjects w…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Sham LaserCap vs. LaserCap SD vs. LaserCap HD+ [NA]
A University of Arizona study is recruiting to compare Sham LaserCap with LaserCap SD and LaserCap HD+ for androgenetic alopecia.
-
FDA approval · 2024-04-22FDA Approved: REGOXIDINE (FOR WOMEN) — Original Application (INNOVUS PHARMACEUTICALS, INC.)
FDA approves REGOXIDINE for Women, a minoxidil topical product, as an original generic application by Innovus Pharmaceuticals (ANDA 218616).
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men [Phase 1, Phase 2]
A Phase 1/2 trial evaluating safety and efficacy of topical DLQ01 for androgenetic alopecia in men has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Phase III Study of KX-826 With Adult Male Patients With AGA [Phase 3]
Phase 3 study update for KX-826 in adult males with androgenetic alopecia (AGA) is in progress; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Use of Botulinum Toxin in the Treatment of Androgenic Alopecia [Phase 2]
Phase 2 trial update on botulinum toxin for androgenetic alopecia (androgenetic alopecia) indicating ongoing status.
-
FDA approval · 2023-10-10FDA Approved: DUTASTERIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
The FDA approved a supplemental application for dutasteride filed by XLCare Pharmaceuticals, Inc., resulting in updated labeling.
-
FDA approval · 2023-10-10FDA Approved: FINASTERIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for finasteride submitted by Ascend Laboratories, LLC, resulting in an approved change to the produc…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men [Phase 3]
Phase 3 trial assessing the effectiveness of combining microneedling with minoxidil for androgenetic alopecia in Indonesian men has complete…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial evaluating the effectiveness and safety of a topical finasteride and minoxidil combination versus topical min…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia [Phase 4]
Phase 4 clinical trial investigating the effectiveness and safety of a combination of platelet-rich plasma and topical 5% minoxidil for male…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA) [Phase 3]
Phase 3 clinical study in patients with androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-208 [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety of AD-208 for androgenetic alopecia has been completed.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Phase II Study Evaluating the Efficacy and Safety of KX-826 [Phase 2]
Phase II study evaluating the efficacy and safety of KX-826 in androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Topical Cetirizine in Androgenetic Alopecia in Females [Phase 2, Phase 3]
Clinical trial update for topical cetirizine in women with androgenetic alopecia, study phases 2 and 3, status completed.
-
FDA approval · 2023-01-23FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited, granting approval for a generic finasteride product u…
-
FDA approval · 2023-01-20FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's supplemental application for Finasteride, granting a supplemental approval under the ANDA for this product.
-
FDA approval · 2023-01-17FDA Approved: FINASTERIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for finasteride submitted by Ascend Laboratories, LLC.
-
FDA approval · 2022-08-01FDA Approved: PROPECIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for PROPECIA (finasteride) from Organon LLC, updating the product labeling.